Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
International Journal of Pharmaceutical Compounding|December 6, 2024
Compatibility of 17-α-Estradiol, Betamethasone, Finasteride, Melatonin, Prednicarbate, and Spironolactone in TrichoFoam™ - a Foaming Vehicle for Personalized Alopecia TreatmentsBruna Marianni, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|September 2, 2022
Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental ConditionsBruna Marianni, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|July 12, 2022
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell CapsulesAnderson de Oliveira Ferreira, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|April 11, 2024
Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of AlopeciaBruna Marianni, Hudson Polonini, Carolina SilvaInternational Journal of Pharmaceutical Compounding|March 31, 2025
Assessing the Compatibility of Different Formulations in OrPhyllo™, A Ready-to-Use Base for Personalized Orodispersible FilmsBruna Marianni, Hudson Polonini, Savvas KoulouridasInternational Journal of Pharmaceutical Compounding|December 16, 2025
Evidence-Based Beyond-Use Dates for Pentravan® Compounded Formulations in Hormone Therapy and Pain ManagementHudson Polonini, Carolina Schettino Kegele, Bruna MarianniInternational Journal of Pharmaceutical Compounding|December 16, 2025
Personalized Orodispersible Films Compounded with OrPhyllo™ Ready-to-use Base: API Compatibility and Evidence-Based Beyond-Use DatesCarolina Schettino Kegele, Bruna Marianni, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|October 20, 2025
SyrSpend® SF PH 4 as a Safe Vehicle for Extemporaneous Oral Suspensions: Microbiological Stability of Seven APIsCarolina Schettino Kegele, Eli Dijkers, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|October 20, 2025
Microbiological and Physical Stability of Extemporaneous Oral Suspensions Compounded with SyrSpend® SF PH4Carolina Schettino Kegele, Eli Dijkers, Hudson PoloniniInternational Journal of Pharmaceutical Compounding|September 17, 2025
Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary EvaluationCarolina Schettino Kegele, Eli Dijkers, Hudson PoloniniPageof 4